Post-COVID-19 Outpatient Care and Biomarkers

Launched by MEDICAL UNIVERSITY OF VIENNA · May 31, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring the long-term effects of COVID-19 on health, specifically looking at conditions like Post Viral Fatigue, Viral Myocarditis, and POTS (Postural Orthostatic Tachycardia Syndrome). The study aims to collect blood samples from patients who have had COVID-19 for at least three weeks after recovering, to analyze various factors in the blood that might help understand ongoing symptoms. Researchers want to see how certain molecules in the blood relate to the symptoms patients experience, which could help improve diagnosis and treatment in the future.

To participate in the study, you must be between 18 and 90 years old and have a confirmed COVID-19 infection. If you are a healthy volunteer, you need to have been fully vaccinated against COVID-19 for at least three weeks. Participants will provide blood samples and may help researchers learn more about the lasting impacts of COVID-19. If you have heart problems or are pregnant, you would not be eligible to join the study. This research is important as it aims to uncover more about the ongoing health issues some people face after recovering from COVID-19.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• For post-COVID patient group:
• • Age≥18to90years
• • Proven infection by SARS-CoV2, at least 3 weeks after recovery from the infection
• * Signed informed consent For HFrEF patient group:
• For vaccinated healthy volunteer control group:
• • Full vaccination against SARS-CoV2 at least 3 weeks before inclusion in the study
• • Signed informed consent
• Exclusion Criteria:
• • non-willingness to participate or withdrawal of informed consent
• • Clinically confirmed HFrEF (EF \<40%)
• • participation in any SARS-CoV-2 medical treatment trial
• • pregnancy